Canaccord Genuity Maintains Buy on UiPath, Raises Price Target to $19

Benzinga · 1d ago
Canaccord Genuity analyst Kingsley Crane maintains UiPath (NYSE:PATH) with a Buy and raises the price target from $15 to $19.